United States · FDA National Drug Code directory
Yuflyma
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72606-030_d8b602aa-a61d-44db-acc7-46f3bc698b24
- Product NDC
- 72606-030
- Form
- KIT
- Composition / generic term
- adalimumab-aaty
- Labeler
- CELLTRION USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20230523 / 20280731
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 2 KIT in 1 CARTON (72606-030-06) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET · 72606-030-06
- 1 KIT in 1 CARTON (72606-030-09) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET · 72606-030-09
- 2 KIT in 1 CARTON (72606-030-10) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET · 72606-030-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →